Answers are grounded in this paper and cite their sources.
Real-world data from Scotland demonstrates that modern therapies have dramatically reduced AMI case-fatality rates since 1986, though post-AMI life expectancy remains significantly compromised.
Population-based case-fatality rates in Scotland have fallen dramatically since 1986, particularly in men. The increasing survival in patients admitted to hospital suggests that the trial-based efficacy of modern therapies is now translating into population-based effectiveness. However, an individual's life expectancy still halves after a diagnosis of acute myocardial infarction. Of the variables that we could examine, age was the most powerful predictor of prognosis.
No takes yet. Share an insight, caveat, or question.
Simon Capewell (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: